Evolutionary, genetic, structural characterization and its functional implications for the influenza A (H1N1) infection outbreak in India from 2009 to 2017

[1]  S. Singh,et al.  Influenza A (H1N1) in India: Changing epidemiology and its implications , 2019, The National medical journal of India.

[2]  Sebastián Duchêne,et al.  BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis , 2018, bioRxiv.

[3]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[4]  M. Suchard,et al.  Posterior summarisation in Bayesian phylogenetics using Tracer , 2022 .

[5]  J. Järhult.  Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary One Health approach including physicians , 2018, Acta Veterinaria Scandinavica.

[6]  Daniel L. Ayres,et al.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10 , 2018, Virus evolution.

[7]  S. Leang,et al.  Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2015. , 2017, Communicable diseases intelligence quarterly report.

[8]  J. Mccammon,et al.  Gaussian Accelerated Molecular Dynamics in NAMD , 2016, Journal of chemical theory and computation.

[9]  Andrew Rambaut,et al.  Origins of the 2009 H1N1 influenza pandemic in swine in Mexico , 2016, eLife.

[10]  Gavin J. D. Smith,et al.  Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection , 2015, Nature Communications.

[11]  Yang Zhang,et al.  I-TASSER server: new development for protein structure and function predictions , 2015, Nucleic Acids Res..

[12]  B. Mishra.  2015 Resurgence of Influenza A (H1N1) 09: Smoldering Pandemic in India? , 2015, Journal of global infectious diseases.

[13]  Luís A. Santos,et al.  Influenza A(H1N1)pdm09 resistance and cross‐decreased susceptibility to oseltamivir and zanamivir antiviral drugs , 2015, Journal of medical virology.

[14]  P. Klapper,et al.  Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence , 2014, Archives of Virology.

[15]  M. Pillai,et al.  Demographic and Clinical Characteristics of Pandemic Influenza A (H1N1) 2009 Outbreak in Kerala, Southern India , 2014 .

[16]  Cécile Viboud,et al.  Correction: Environmental Predictors of Seasonal Influenza Epidemics across Temperate and Tropical Climates , 2013, PLoS Pathogens.

[17]  A. García-Sastre,et al.  Evolution of the Hemagglutinin Protein of the New Pandemic H1N1 Influenza Virus: Maintaining Optimal Receptor Binding by Compensatory Substitutions , 2013, Journal of Virology.

[18]  C. Viboud,et al.  Environmental Predictors of Seasonal Influenza Epidemics across Temperate and Tropical Climates , 2013, PLoS pathogens.

[19]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[20]  J. McKimm-Breschkin,et al.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance , 2013, Influenza and other respiratory viruses.

[21]  D. Borchelt,et al.  Correction: Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines , 2012, PLoS ONE.

[22]  S. van der Werf,et al.  I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y , 2012, PloS one.

[23]  D. Burton,et al.  Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses , 2012, Science.

[24]  C. Davis,et al.  Evolutionary History and Phylodynamics of Influenza A and B Neuraminidase (NA) Genes Inferred from Large-Scale Sequence Analyses , 2012, PloS one.

[25]  D. Rawat,et al.  Emergence of pandemic 2009 influenza A H1N1, India , 2012, The Indian journal of medical research.

[26]  C. H. Camargo,et al.  Peritoneal Dialysis-Related Peritonitis Due to Staphylococcus aureus: A Single-Center Experience over 15 Years , 2012, PloS one.

[27]  I. Wilson,et al.  Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic , 2011, Journal of Virology.

[28]  Samir Bhatt,et al.  The genomic rate of molecular adaptation of the human influenza A virus. , 2011, Molecular biology and evolution.

[29]  N. Saksena,et al.  Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. , 2010, Antiviral research.

[30]  Kimihito Ito,et al.  Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin , 2010, PloS one.

[31]  Timothy B. Stockwell,et al.  The early diversification of influenza A/H1N1pdm , 2009, PLoS currents.

[32]  Yi Guan,et al.  Dating the emergence of pandemic influenza viruses , 2009, Proceedings of the National Academy of Sciences.

[33]  Derek Gatherer,et al.  The 2009 H1N1 influenza outbreak in its historical context. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[34]  N. Bovin,et al.  Influenza Virus Neuraminidase: Structure and Function , 2009, Acta naturae.

[35]  Gavin J. D. Smith,et al.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.

[36]  Geoffrey J. Barton,et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..

[37]  C. Basler,et al.  Neutralizing Anti-Influenza Virus Monoclonal Antibodies: Therapeutics and Tools for Discovery , 2009, International reviews of immunology.

[38]  D. Posada.  jModelTest: phylogenetic model averaging. , 2008, Molecular biology and evolution.

[39]  E. Holmes,et al.  Rates of evolutionary change in viruses: patterns and determinants , 2008, Nature Reviews Genetics.

[40]  Yang Zhang,et al.  I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.

[41]  T. Tatusova,et al.  The Influenza Virus Resource at the National Center for Biotechnology Information , 2007, Journal of Virology.

[42]  I. Barr,et al.  Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors , 2006, Expert review of anti-infective therapy.

[43]  Cécile Viboud,et al.  Influenza in Tropical Regions , 2006, PLoS medicine.

[44]  Yang Zhang,et al.  Scoring function for automated assessment of protein structure template quality , 2004, Proteins.

[45]  J. Treanor.  Influenza vaccine--outmaneuvering antigenic shift and drift. , 2004, The New England journal of medicine.

[46]  Gert Vriend,et al.  Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.

[47]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[48]  G. Oliva,et al.  Crystallographic and spectroscopic characterization of a molecular hinge: Conformational changes in bothropstoxin I, a dimeric Lys49‐phospholipase A2 homologue , 1998, Proteins.

[49]  J. Yewdell,et al.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) , 1982, Cell.